# South America Ophthalmic Viscoelastic Devices Market

> South America Ophthalmic Viscoelastic Devices Market Research Report: Size, Share, Trend Analysis By Types (Cohesive OVDs, Dispersive OVDs), By Applications (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery), By End Users (Ophthalmic Clinics & Phaco Centers, Hospitals, Academic & Research Institutes) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 4.99%
- **2024:** $ 170.4 Million
- **2025:** $ 259.2 Million
- **2035:** $ 291.2 Million
- **Key Players:** Alcon (CH), Bausch + Lomb (US), Johnson & Johnson (US), Carl Zeiss (DE), Hoya Corporation (JP), Santen Pharmaceutical (JP), Abbott Laboratories (US), Merck & Co. (US)

**Report ID:** MRFR/MED/54235-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-america-ophthalmic-viscoelastic-devices-market-56001

---

## Market Summary

## **South America Ophthalmic Viscoelastic Devices Market Overview**

As per MRFR analysis, the South America Ophthalmic Viscoelastic Devices Market Size was estimated at 228.8 (USD Million) in 2023. The South America Ophthalmic Viscoelastic Devices Market Industry is expected to grow from 245.6(USD Million) in 2024 to 467 (USD Million) by 2035. The South America Ophthalmic Viscoelastic Devices Market CAGR (growth rate) is expected to be around 6.016% during the forecast period (2025 - 2035).

**Key South America Ophthalmic Viscoelastic Devices Market Trends Highlighted**

The South America ophthalmic viscoelastic devices market is witnessing noteworthy trends driven by increasing eye-related disorders, particularly cataracts and glaucoma, which are becoming more prevalent in the region. The aging population, coupled with lifestyle factors and urbanization, is contributing to a greater demand for surgical procedures, thus enhancing the market for viscoelastic devices.

Additionally, advancements in surgical technologies and techniques are also key market drivers, as they enable healthcare providers to perform more complex eye surgeries, thereby increasing reliance on these devices for improved outcomes and patient comfort.

The South America ophthalmic viscoelastic devices market holds notable untapped potential, especially in Brazil and Argentina, which are front runners in performing ophthalmic surgeries. The developing healthcare infrastructure and increased spending on healthcare services will further increase the demand for ophthalmic viscoelastic devices.

In addition, local manufacturers are starting to make headway, which can lower the prices of products as well as drive innovative change designed specifically for the region. Recent developments show that there is an improvement in the safety and effectiveness of eye surgeries as well as better control of complications with greater use of advanced viscoelastic materials during surgery.

Patients are increasingly opting for minimally invasive surgical techniques, which are driving the demand for high-quality viscoelastic devices that can facilitate these procedures.

Collaboration between healthcare providers and medical device manufacturers is also on the rise, aiming to enhance product offerings and ensure that devices meet clinical requirements specific to South America. Overall, these trends highlight a dynamic and growing market in South America that is well-positioned for continued development in the ophthalmic viscoelastic devices sector.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**South America Ophthalmic Viscoelastic Devices Market Drivers**

**Increasing Prevalence of Eye Disorders**

The rise in eye disorders in South America significantly drives the growth of the South America Ophthalmic Viscoelastic Devices Market Industry. According to the Pan American Health Organization, over 70 million people in South America suffer from various forms of visual impairments, most of which require surgical intervention.

The correlation of an aging population with the rise in conditions such as cataracts and glaucoma forms a critical market driver.The Brazilian Society of Ophthalmology has reported that cataracts remain the leading cause of blindness in the country, necessitating the use of advanced surgical tools, including ophthalmic viscoelastic devices. Such a steep demand underscores the importance of innovation and the availability of these devices to enhance surgical outcomes, pushing market growth further.

**Technological Advancements in Surgical Procedures**

Technological advancements in ophthalmic surgery significantly fuel the South America Ophthalmic Viscoelastic Devices Market Industry. Innovations such as femtosecond laser-assisted cataract surgery have transformed traditional surgical techniques, providing enhanced precision and outcomes.

The Brazilian Ministry of Health has reported an upsurge in the adoption of these advanced techniques, which require effective viscoelastic devices to maintain eye pressure and protect delicate ocular tissues during procedures.Manufacturers like Alcon and Bausch + Lomb have begun to focus on developing advanced formulation viscoelastics that cater specifically to the needs of modern surgical practices, thus increasing the demand for such devices in the region.

**Government Initiatives and Improved Healthcare Infrastructure**

Government initiatives aimed at improving healthcare infrastructure in South America play a vital role in enhancing the South America Ophthalmic Viscoelastic Devices Market Industry. For instance, initiatives by the Argentine government to increase funding for public health services have resulted in improved medical facilities and access to quality eye care services.

According to the Ministry of Health of Argentina, they have allocated funds that have led to the establishment of over 300 new eye clinics nationwide.This strategic investment in healthcare directly stimulates demand for ophthalmic surgeries, thereby increasing the requirement for viscoelastic devices essential for these procedures.

**South America Ophthalmic Viscoelastic Devices Market Segment Insights**

**Ophthalmic Viscoelastic Devices Market Type Insights**

The South America Ophthalmic Viscoelastic Devices Market demonstrates a diverse Type segmentation with notable categories, including Cohesive Ocular Viscoelastic Devices (OVDs) and Dispersive OVDs. Each of these categories plays a distinct role in ophthalmic surgical procedures, particularly in cataract surgeries and other ocular interventions.

Cohesive OVDs are well-regarded for their stability and ability to maintain space within the anterior chamber of the eye, making them essential for surgeons aiming for precision and safety during operations. On the other hand, Dispersive OVDs are invaluable due to their capability to protect corneal endothelial cells, which are critical in preserving long-term visual acuity.

As the demand for ophthalmic surgeries grows within South America, primarily driven by an increasing aging population and rising cases of ocular diseases, the importance of these devices escalates. Moreover, advancements in technology have led to enhanced formulations of both cohesive and dispersive devices, ensuring better outcomes for patients and driving the industry forward.

The South America Ophthalmic Viscoelastic Devices Market has seen a trend toward the integration of innovative designs and materials, further emphasizing the importance of these segments in achieving successful surgical results. Overall, the continuous development and growing understanding of the respective properties and applications of Cohesive and Dispersive OVDs contribute significantly to market growth in South America.

The increased prevalence of ophthalmic conditions, alongside the technological advancements, ensures that both these segments will play crucial roles in shaping the future landscape of the ophthalmology industry within the region, responding to the rising needs for healthcare services and improving patient safety and outcomes.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Ophthalmic Viscoelastic Devices Market Application Insights**

The South America Ophthalmic Viscoelastic Devices Market, particularly in the Application segment, is observing substantial growth driven by various surgical procedures. Cataract Surgery stands out as a key contributor, given the high prevalence of cataracts in the aging population, creating notable demand for effective viscoelastic devices that enhance surgical efficiency.

Glaucoma Surgery is also on the rise, primarily due to increasing awareness and diagnosis rates related to this chronic condition, leading to a significant market presence. Corneal Transplantation procedures benefit from advancements in technology, as these devices facilitate better surgical outcomes and patient recovery.

Additionally, Vitreoretinal Surgery is gaining traction, driven by the rising incidence of retinal diseases and enhancing surgical precision. The increasing investment in healthcare infrastructure and the growing geriatric population in South America further bolster the importance of these applications within the South America Ophthalmic Viscoelastic Devices Market. Overall, these applications play a crucial role in addressing the region’s healthcare needs, showcasing a strong trajectory for future growth and innovation.

**Ophthalmic Viscoelastic Devices Market End User Insights**

The South America Ophthalmic Viscoelastic Devices Market is significantly shaped by its diverse End User segment, which comprises Ophthalmic Clinics and Phaco Centers, Hospitals, and Academic and Research Institutes. Ophthalmic Clinics and Phaco Centers serve as crucial nodes for procedures utilizing viscoelastic devices, driving demand due to an increasing number of cataract surgeries and advancements in surgical techniques.

Hospitals play a pivotal role in providing a broad spectrum of ophthalmic care, accommodating various patient needs, which contributes to their essential presence in the market.Meanwhile, Academic and Research Institutes are fundamental in fostering innovation and improvement in ophthalmic procedures, emphasizing the importance of research and development.

With South America experiencing a growing prevalence of eye-related disorders, there is a promising outlook for these segments, as they are consistently evolving to meet the present healthcare demands, which further highlights their integral role in enhancing patient outcomes and advancing medical practices in the region. The overall landscape is one of gradual growth, with each End User segment playing its part in responding to emerging trends and the evolving healthcare environment.

**Ophthalmic Viscoelastic Devices Market Regional Insights**

The South America Ophthalmic Viscoelastic Devices Market is characterized by a diverse regional landscape, with significant contributions from Brazil, Mexico, Argentina, and the Rest of South America. Brazil stands as a key player in this market, driven by its large population and a growing prevalence of eye-related disorders, which necessitates advanced surgical interventions.

Mexico also plays a vital role, with an increasing healthcare infrastructure and a rise in ophthalmic surgical procedures contributing to market growth. Argentina's emphasis on improving healthcare services, accompanied by an uptick in eye surgeries, creates a substantial demand for ophthalmic viscoelastic devices.Meanwhile, the Rest of South America reflects a mix of emerging markets where government initiatives and an escalating focus on eye health significantly impact market dynamics.

Collectively, these regions exhibit a trend towards modernization in healthcare facilities, fostering greater accessibility to advanced ophthalmic solutions. The rising awareness of eye health and the increasing incidence of cataracts and glaucoma in the population are further pushing demand across these regions, showcasing a promising growth trajectory for the South America Ophthalmic Viscoelastic Devices Market.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**South America Ophthalmic Viscoelastic Devices Market Key Players and Competitive Insights**

The South America Ophthalmic Viscoelastic Devices Market has been witnessing significant growth, driven by the increasing prevalence of eye diseases and rising awareness about eye health and vision correction. The competitive landscape in this market is characterized by a mix of local and global players that are vying for market share.

The dynamic nature of this market is influenced by ongoing technological advancements, aggressive marketing strategies, and a focus on product innovation. Players are continuously looking to enhance their portfolio with effective ophthalmic viscoelastic devices designed for various eye surgeries, including cataracts and retinal procedures. Factors such as regulatory compliance and establishing distribution networks play a critical role in determining the competitive standing of each market participant.

The increasing demand for minimally invasive surgeries is also shaping strategies among competitors as they adapt to physician and patient preferences within this region. AbbVie has a noteworthy presence in the South America Ophthalmic Viscoelastic Devices Market, leveraging its strong reputation and established portfolio to cater to the needs of ophthalmology professionals and patients alike.

The company’s commitment to research and development is exemplified through innovative products that address the unique challenges faced in eye surgeries. Its strengths primarily lie in a strong distribution network and strategic partnerships that enable it to reach a wider audience effectively. The company's ability to provide high-quality viscoelastic devices tailored for various surgical applications has positioned it favorably in competitive assessments.

AbbVie's investment in clinical research specific to regional health challenges further enhances its credibility among healthcare providers, showcasing its dedication to improving patient outcomes in South America

.Lumenis also plays a significant role within the South America Ophthalmic Viscoelastic Devices Market, focusing on advanced surgical and aesthetic solutions for ophthalmology. Known for its core competencies in laser and energy-based technologies, Lumenis has developed specialized viscoelastic products designed for complex eye surgeries. The company capitalizes on its strong brand recognition and expertise in innovation, allowing it to maintain a competitive edge.

Lumenis strengthens its market position through strategic mergers and acquisitions, which expand its product offerings and geographic reach. Additionally, the company actively invests in marketing initiatives, educational programs, and collaborations with local healthcare providers to enhance awareness of its key products. Through these strategies, Lumenis aims to solidify its dominance in the ophthalmic sector and cater specifically to the needs of South American patients and surgeons.

**Key Companies in the South America Ophthalmic Viscoelastic Devices Market Include**

- AbbVie
- Lumenis
- Surgerii
- Medtronic
- Bausch Health
- MediDate
- Hoya Corporation
- Santen Pharmaceutical
- EyeCees
- Carl Zeiss AG
- AMO
- Rayner
- Alcon
- Eye de la Marque
- SIBF

**South America Ophthalmic Viscoelastic Devices Market Industry Developments**

The South America Ophthalmic Viscoelastic Devices Market has seen significant developments recently, driven by increasing eye surgeries and advancements in technology. In October 2023, Bausch Health announced the launch of a new viscoelastic device specifically designed for cataract surgery, which has garnered attention for its innovative formulation.

Additionally, in September 2023, Alcon expanded its product range in Brazil, aiming to enhance service and availability in the region. Current affairs indicate that companies like AbbVie and Medtronic are focusing on strategic partnerships to elevate their market presence.

Market valuations have experienced growth, with forecasts showing an upward trend driven by an aging population and rising awareness about eye health in South America. Notably, in August 2023, Hoya Corporation acquired a small local firm specializing in eye health solutions to diversify its offerings.

Furthermore, competitive dynamics among key players, including Carl Zeiss AG and Santen Pharmaceutical, highlight a healthy growth environment for Ophthalmic Viscoelastic Devices, which are becoming increasingly essential in surgical procedures across countries like Brazil and Argentina. The evolving regulatory landscape is also facilitating the introduction of new technologies in the region.

**South America Ophthalmic Viscoelastic Devices Market Segmentation Insights**

**Ophthalmic Viscoelastic Devices Market Type****Outlook**

- Cohesive OVDs
- Dispersive OVDs

**Ophthalmic Viscoelastic Devices Market Application****Outlook**

- Cataract Surgery
- Glaucoma Surgery
- Corneal Transplantation
- Vitreoretinal Surgery

**Ophthalmic Viscoelastic Devices Market End User****Outlook**

- Ophthalmic Clinics & Phaco Centers
- Hospitals
- Academic & Research Institutes

**Ophthalmic Viscoelastic Devices Market Regional****Outlook**

- Brazil
- Mexico
- Argentina
- Rest of South America

## Market Drivers

### Rising Geriatric Population

The demographic shift towards an aging population in South America is a significant driver for the Ophthalmic Viscoelastic Devices Market. As the geriatric population continues to grow, the incidence of age-related eye conditions, such as cataracts and macular degeneration, is likely to rise. Reports indicate that by 2030, the number of individuals aged 65 and older in South America will exceed 100 million, creating a substantial demand for surgical interventions. This demographic trend necessitates the use of advanced viscoelastic devices during cataract surgeries, as they play a crucial role in maintaining intraocular pressure and protecting ocular tissues. Consequently, the market is poised for growth as healthcare providers adapt to the needs of this aging population, ensuring that high-quality ophthalmic viscoelastic devices are readily available.

### Increasing Prevalence of Eye Disorders

The South America Ophthalmic Viscoelastic Devices Market is experiencing growth due to the rising prevalence of eye disorders, particularly cataracts and glaucoma. According to regional health statistics, the incidence of cataracts is projected to increase significantly, with estimates suggesting that by 2025, over 30% of the population aged 60 and above may be affected. This demographic shift necessitates a greater demand for surgical interventions, thereby driving the need for advanced ophthalmic viscoelastic devices. Furthermore, the growing awareness of eye health and the importance of regular eye examinations contribute to the rising demand for these devices, as patients seek timely treatment options. As healthcare systems in South America continue to evolve, the focus on improving surgical outcomes and patient safety further emphasizes the critical role of viscoelastic devices in ophthalmic procedures.

### Growing Awareness and Patient Education

Increasing awareness regarding eye health and the importance of timely surgical interventions is driving the South America Ophthalmic Viscoelastic Devices Market. Educational campaigns and community outreach programs are effectively informing the public about the risks associated with untreated eye conditions, particularly cataracts. As patients become more informed, they are more likely to seek surgical options, thereby increasing the demand for viscoelastic devices. Additionally, the rise of digital health platforms and telemedicine has facilitated access to information, allowing patients to connect with healthcare providers more easily. This trend is expected to continue, with projections indicating a steady increase in patient inquiries about cataract surgeries and the associated technologies. As a result, the market for ophthalmic viscoelastic devices is likely to expand, driven by a more educated patient base seeking optimal surgical outcomes.

### Technological Innovations in Surgical Procedures

Technological advancements in surgical techniques and devices are significantly influencing the South America Ophthalmic Viscoelastic Devices Market. Innovations such as minimally invasive surgical methods and the development of new viscoelastic formulations enhance the efficiency and safety of cataract surgeries. For instance, the introduction of cohesive and dispersive viscoelastics allows for better control during surgery, reducing complications and improving patient outcomes. The market is projected to grow at a compound annual growth rate (CAGR) of approximately 6% over the next five years, driven by these technological improvements. Additionally, the integration of digital technologies in surgical settings, such as real-time imaging and automated systems, further enhances the precision of ophthalmic procedures, thereby increasing the reliance on high-quality viscoelastic devices.

### Government Initiatives and Healthcare Investments

Government initiatives aimed at improving healthcare infrastructure in South America are playing a pivotal role in the growth of the Ophthalmic Viscoelastic Devices Market. Various countries in the region are investing in healthcare reforms that prioritize eye care services, including the establishment of specialized ophthalmic centers. For example, Brazil's Ministry of Health has launched programs to enhance access to cataract surgeries, which directly correlates with the demand for viscoelastic devices. These investments not only improve surgical capabilities but also foster partnerships with device manufacturers, ensuring the availability of advanced products. As a result, the market is expected to benefit from increased funding and support for eye health initiatives, ultimately leading to a higher adoption rate of ophthalmic viscoelastic devices.

## Future Outlook

The South America [Ophthalmic Viscoelastic Devices Market](https://www.marketresearchfuture.com/reports/ophthalmic-viscoelastic-devices-market-1396) is projected to grow at a 4.99% CAGR from 2025 to 2035, driven by increasing surgical procedures and technological advancements.

**New opportunities:**

- Expansion of product lines to include biodegradable viscoelastics.
- Development of strategic partnerships with local healthcare providers.
- Investment in digital marketing strategies targeting ophthalmic surgeons.

By 2035, the market is expected to solidify its position as a key player in ophthalmic innovations.

## Segment Insights

### By Application: Cataract Surgery (Largest) vs. Glaucoma Surgery (Fastest-Growing)

The South America Ophthalmic Viscoelastic Devices Market exhibits a diverse range of applications, with cataract surgery securing the largest market share. This dominance is primarily attributed to the high prevalence of cataracts across the region, driven by an aging population and increased awareness of surgical options. Following this, glaucoma surgery is gaining traction as a significant segment, reflecting the rising incidence of glaucoma and the need for advanced surgical interventions. The market distribution showcases cataract surgery as a cornerstone, while other applications carve their niches in response to specific ophthalmic needs.

Cataract Surgery (Dominant) vs. Glaucoma Surgery (Emerging)

Cataract surgery has long been the dominant application in the South America Ophthalmic Viscoelastic Devices Market, thanks to advancements in surgical techniques and the widespread implementation of viscoelastic devices that enhance procedural efficiency. The segment appeals to a broad demographic, addressing the needs of patients experiencing vision impairment due to cataracts. In contrast, glaucoma surgery is an emerging application that is quickly gaining prominence. Factors driving this growth include the increasing awareness of glaucoma's impact on vision health and a shift towards more effective surgical solutions. As more healthcare providers adopt innovative treatment methods for glaucoma, the demand for specialized viscoelastic devices is expected to grow, indicating a dynamic shift in the market landscape.

### By End Use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the South America Ophthalmic Viscoelastic Devices Market, hospitals are the predominant end-use segment, leveraging their established infrastructure and comprehensive service offerings to capture a significant market share. Ambulatory surgical centers, however, are rapidly gaining traction, driven by increasing demand for outpatient procedures and shorter recovery times. Together, these segments are shaping the landscape of ophthalmic surgeries in the region, with hospitals providing a solid foundation while ambulatory centers inject dynamism into the market.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals are the dominant end-use segment, characterized by high patient volume and the capability to conduct complex procedures. They benefit from advanced technologies and skilled healthcare professionals, making them the preferred choice for major ophthalmic surgeries. In contrast, ambulatory surgical centers are emerging as a significant force, favored for their efficiency and lower operational costs. These centers are increasingly sought after for elective procedures, allowing patients to undergo surgery and return home the same day. The shift toward minimally invasive surgeries and outpatient care is solidifying the position of ambulatory centers, positioning them as a crucial player in the evolving ophthalmic landscape.

### By Product Type: Dispersive Viscoelastic Devices (Largest) vs. Combination Viscoelastic Devices (Fastest-Growing)

In the South America Ophthalmic Viscoelastic Devices Market, Dispersive Viscoelastic Devices hold the largest market share, valued for their ability to maintain intraocular pressure and protect the corneal endothelium during cataract surgeries. Their established presence and clinical reliability make them a preferred choice among ophthalmic surgeons. On the other hand, Combination Viscoelastic Devices, which incorporate both dispersive and cohesive properties, are gaining ground due to their versatility and effectiveness in various surgical applications. This segment's market share continues to grow as surgeons seek options that can provide optimal performance under diverse surgical conditions.

Dispersive Viscoelastic Devices (Dominant) vs. Combination Viscoelastic Devices (Emerging)

Dispersive Viscoelastic Devices are characterized by their high molecular weight, providing excellent protection to the ocular tissues during surgery. They are highly effective at maintaining space within the anterior segment of the eye and minimizing trauma. As the dominant product type, they are widely used in procedures like cataract extractions. In contrast, Combination Viscoelastic Devices are emerging as a competitive option, leveraging the benefits of both cohesive and dispersive properties. They offer the surgeon greater flexibility, often used in complex surgeries where both stability and protection are required. This adaptability is driving their popularity, positioning them strongly in a rapidly evolving market.

### By Material Type: Sodium Hyaluronate (Largest) vs. Chondroitin Sulfate (Fastest-Growing)

In the South America Ophthalmic Viscoelastic Devices Market, Sodium Hyaluronate stands out as the largest material type due to its widespread use in surgical procedures and its established efficacy in maintaining ocular hydration and viscosity. Following closely is Chondroitin Sulfate, which, while not as dominant currently, has gained attention for its unique properties, leading to a growing market share in specific applications, particularly in cataract surgeries.

Sodium Hyaluronate (Dominant) vs. Chondroitin Sulfate (Emerging)

Sodium Hyaluronate remains the dominant material in the South America ophthalmic viscoelastic devices landscape, attributed to its high biocompatibility and proven effectiveness in a variety of eye surgeries. It is favored for its ability to retain moisture, thereby improving surgical outcomes and patient comfort. In contrast, Chondroitin Sulfate is emerging as a notable alternative, garnering attention for its potential to enhance healing and reduce inflammation during post-operative recovery. As surgeons increasingly seek biocompatible options with additional therapeutic benefits, Chondroitin Sulfate is positioned for significant growth in the upcoming years, capitalizing on the innovation and demand for enhanced surgical solutions.

## Regional Market Share Analysis

The South America Ophthalmic Viscoelastic Devices Market is characterized by a diverse regional landscape, with significant contributions from Brazil, Mexico, Argentina, and the Rest of South America. Brazil stands as a key player in this market, driven by its large population and a growing prevalence of eye-related disorders, which necessitates advanced surgical interventions.

Mexico also plays a vital role, with an increasing healthcare infrastructure and a rise in ophthalmic surgical procedures contributing to market growth. Argentina's emphasis on improving healthcare services, accompanied by an uptick in eye surgeries, creates a substantial demand for ophthalmic viscoelastic devices.Meanwhile, the Rest of South America reflects a mix of emerging markets where government initiatives and an escalating focus on eye health significantly impact market dynamics.

Collectively, these regions exhibit a trend towards modernization in healthcare facilities, fostering greater accessibility to advanced ophthalmic solutions. The rising awareness of eye health and the increasing incidence of cataracts and glaucoma in the population are further pushing demand across these regions, showcasing a promising growth trajectory for the South America Ophthalmic Viscoelastic Devices Market.

## Competitive Benchmarking

The Ophthalmic Viscoelastic Devices Market in South America is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Alcon (CH), Bausch + Lomb (US), and Johnson & Johnson (US) are actively pursuing strategies that emphasize product development and market penetration. Alcon (CH), for instance, has focused on enhancing its product portfolio through continuous innovation, which appears to be a critical driver of its competitive edge. Meanwhile, Bausch + Lomb (US) has been leveraging strategic partnerships to bolster its distribution channels, thereby enhancing its market presence. Johnson & Johnson (US) seems to be concentrating on digital transformation initiatives, which may facilitate improved customer engagement and operational efficiency, collectively shaping a dynamic competitive environment.

The business tactics employed by these companies reflect a nuanced understanding of the market's structure, which is moderately fragmented. Localizing manufacturing and optimizing supply chains are prevalent strategies that enable these firms to respond swiftly to regional demands. The collective influence of these key players suggests a competitive structure where innovation and operational efficiency are paramount, allowing them to navigate the complexities of the market effectively.

In December 2025, Alcon (CH) announced the launch of a new line of advanced viscoelastic devices designed specifically for cataract surgery, which is anticipated to enhance surgical outcomes. This strategic move underscores Alcon's commitment to innovation and positions the company to capture a larger share of the growing surgical market in South America. The introduction of these devices may not only improve patient outcomes but also strengthen Alcon's competitive positioning against its rivals.

In November 2025, Bausch + Lomb (US) entered into a strategic alliance with a local distributor in Brazil, aimed at expanding its reach in the South American market. This partnership is likely to enhance Bausch + Lomb's distribution capabilities, allowing for more efficient product delivery and increased market penetration. Such collaborations may prove essential in navigating the diverse regulatory landscapes across the region, thereby solidifying the company's foothold in the market.

In October 2025, Johnson & Johnson (US) unveiled a new digital platform designed to streamline the purchasing process for ophthalmic devices, which could significantly enhance customer experience. This initiative reflects a broader trend towards digitalization within the industry, suggesting that Johnson & Johnson is keen on leveraging technology to differentiate itself from competitors. The platform may facilitate better customer engagement and operational efficiencies, aligning with the company's strategic focus on innovation.

As of January 2026, the competitive trends within the Ophthalmic Viscoelastic Devices Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are playing a pivotal role in shaping the current landscape, enabling companies to enhance their capabilities and market reach. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, which may ultimately redefine the market dynamics.

## Recent News & Developments

The South America Ophthalmic Viscoelastic Devices Market has seen significant developments recently, driven by increasing eye surgeries and advancements in technology. In October 2023, Bausch Health announced the launch of a new viscoelastic device specifically designed for cataract surgery, which has garnered attention for its innovative formulation.

Additionally, in September 2023, Alcon expanded its product range in Brazil, aiming to enhance service and availability in the region. Current affairs indicate that companies like AbbVie and Medtronic are focusing on strategic partnerships to elevate their market presence.

Market valuations have experienced growth, with forecasts showing an upward trend driven by an aging population and rising awareness about eye health in South America. Notably, in August 2023, Hoya Corporation acquired a small local firm specializing in eye health solutions to diversify its offerings.

Furthermore, competitive dynamics among key players, including Carl Zeiss AG and Santen Pharmaceutical, highlight a healthy growth environment for Ophthalmic Viscoelastic Devices, which are becoming increasingly essential in surgical procedures across countries like Brazil and Argentina. The evolving regulatory landscape is also facilitating the introduction of new technologies in the region.

## Report Scope

| MARKET SIZE 2024 | 170.4(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 259.2(USD Million) |
| MARKET SIZE 2035 | 291.2(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.99% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Alcon (CH), Bausch + Lomb (US), Johnson & Johnson (US), Carl Zeiss (DE), Hoya Corporation (JP), Santen Pharmaceutical (JP), Abbott Laboratories (US), Merck & Co. (US) |
| Segments Covered | Application, End Use, Product Type, Material Type |
| Key Market Opportunities | Growing demand for advanced surgical procedures drives innovation in South America Ophthalmic Viscoelastic Devices Market. |
| Key Market Dynamics | Rising demand for advanced surgical procedures drives growth in South America Ophthalmic Viscoelastic Devices Market. |
| Countries Covered | Brazil, Mexico, Argentina, Rest of South America |

## Frequently Asked Questions

**Q: What is the current valuation of the South America Ophthalmic Viscoelastic Devices Market?**
A: The market valuation was 170.4 USD Million in 2024.

**Q: What is the projected market size for the South America Ophthalmic Viscoelastic Devices Market by 2035?**
A: The market is expected to reach 291.2 USD Million by 2035.

**Q: What is the expected CAGR for the South America Ophthalmic Viscoelastic Devices Market during the forecast period?**
A: The expected CAGR for the market from 2025 to 2035 is 4.99%.

**Q: Which application segment had the highest valuation in 2024?**
A: Cataract Surgery had the highest valuation at 68.4 USD Million in 2024.

**Q: What are the projected values for the Glaucoma Surgery segment by 2035?**
A: The Glaucoma Surgery segment is projected to reach 57.6 USD Million by 2035.

**Q: Which end-use segment is anticipated to grow the most by 2035?**
A: The Hospitals segment is expected to grow to 115.0 USD Million by 2035.

**Q: What is the market value of Combination Viscoelastic Devices in 2024?**
A: The market value for Combination Viscoelastic Devices was 70.4 USD Million in 2024.

**Q: Which material type is projected to have the highest valuation by 2035?**
A: Sodium Hyaluronate is projected to reach 145.0 USD Million by 2035.

**Q: Who are the key players in the South America Ophthalmic Viscoelastic Devices Market?**
A: Key players include Alcon, Bausch + Lomb, Johnson & Johnson, and others.

**Q: What is the expected growth trend for the South America Ophthalmic Viscoelastic Devices Market?**
A: The market is likely to experience steady growth, driven by advancements in surgical techniques and increasing demand.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-america-ophthalmic-viscoelastic-devices-market-56001*